The question is no longer whether healthcare innovation is accelerating. The question is where investors gain access to ...
Drug spending continues to grow, but that doesn’t mean that everyone is getting the medicines that they need. A panel at ...
Health tech investors say the founders who win them over aren't the ones with all the answers, but the ones who know exactly ...
As a member of the Coalition Against Surprise Medical Billing, Katy Spangler helped push for the No Surprises Act in 2020. However, on Wednesday, she took the stage at the AHIP Medicare, Medicaid, ...
Assured Health raised $19 million for its AI agents that verify provider credentials and manage insurance enrollment for ...
For many people, managing a disease means chronic therapy. Scribe Therapeutics has a different vision: genetic medicines that offer durable effects for the masses. With its lead program on a path to ...
Healthcare AI company Innovaccer announced on Wednesday that it is committing $250 million over the next three years to build out its platform of AI agents, which perform tasks across five main ...
Hospitals that see improved long-term results in behavioral health patients will be those that prioritize metrics aligned ...
Headspace, a mental health company, announced on Tuesday that it is expanding its specialty care ecosystem with partnerships ...
SCAN Health Plan CEO Sachin Jain and Ascendiun CEO Paul Markovich argued that healthcare leaders share responsibility for the ...
Groundbreaking new therapies have exciting potential to treat and cure diseases while minimizing burden on patients; however, ...
Neuropsychiatric drug development is rife with clinical trial failures, but Alto Neuroscience aims to overcome these hurdles with a precision medicine approach that matches a patient to a drug. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results